SCHEMBL4036859

SCHEMBL4036859

CCCCNC(=O)C(c1ccc(Cl)cc1)C1(c2ccc(OC)cc2OC)Nc2ccccc2N1

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CTSD P07339 3/20 0.40
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.37
PTPN1 P18031 1/20 0.36
PAX8 Q06710 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4043634 0.95 CTSD (0.42) CTSDALDH1A1LMNAMEN1KMT2A
SCHEMBL4043642 0.93 CTSD (0.46) CTSDALDH1A1LMNAMEN1KMT2A
SCHEMBL4038953 0.90 HCRTR1 (0.43) CTSDALDH1A1LMNAMEN1KMT2A
SCHEMBL4044341 0.84 C5AR1 (0.40) CTSDALDH1A1MEN1KMT2AHDAC3
SCHEMBL4036919 0.82 CNR1 (0.38) CTSDALDH1A1PTPN1
SCHEMBL4040091 0.77 LMNA (0.40) CTSDLMNAMEN1KMT2APAX8
SCHEMBL4035711 0.77 TSHR (0.42) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL4043117 0.70 MEN1 (0.46) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL4039895 0.70 GAA (0.41) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL4043313 0.70 TSHR (0.38) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed